Fujifilm Holdings Corporation operates in the X-ray apparatus and tubes sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fujifilm Holdings with three other
medical equipment manufacturers in Asia:
sales of 587.78 billion Japanese Yen [US$5.21 billion]
of which 55%
was Cardiovascular area business),
(786.50 billion Japanese Yen [US$6.98 billion]
of which 78%
was Medical Care), and
(395.40 billion Japanese Yen [US$3.51 billion]
of which 76%
was Medical Care).
Fujifilm Holdings reported sales of ¥2.43 trillion (US$21.58 billion)
March of 2018.
increase of 4.8%
versus 2017, when the company's sales were ¥2.32 trillion.
Despite this increase, sales are still
below the level achieved in 2016, when Fujifilm Holdings
reported sales of ¥2.49 trillion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Fujifilm Holdings had sales
of ¥2.21 trillion.
Sales of Imaging Solutions saw an increase
that was more than double the company's growth rate: sales were up
12.1% in 2018, from
¥341.74 billion to ¥382.96 billion.
Fujifilm Holdings also saw significant increases in sales in
Information Solutions (up 11.5% to ¥1.00 trillion)
Not all segments of Fujifilm Holdings experienced an increase in sales in 2018:
sales of Document Solutions fell 3.1% to ¥1.05 trillion.